Experimental Ebola drug said to be exhausted

US Company, Mapp Biopharmaceuticals that manufactures the medication ZMapp which is used to treat people with Ebola says the drug is exhausted. 

The company in a statement says they have complied with every request for the drug that had the necessary legal and regulatory authorization. 

The company however declined to say where the drugs have been sent but said in all cases it was provided at no cost. 

Meanwhile, Canada says it will donate up to one thousand doses of an experimental Ebola vaccine to help battle the disease's outbreak in West Africa. 

It comes after the WHO said it is ethical to use untested drugs on Ebola patients. 

Canada says between 800 and one thousand doses of the vaccine, known as VSV-EBOV, which has only been tested on animals, will be donated to the WHO for use in West Africa. 

However, it will keep a small portion of the vaccine for research, and in case it is needed in Canada. 

The Deputy Head of Canada's Public Health Agency, Dr Gregory Taylor, said the Agency could be discussing options with international partners and WHO over the coming days to try to come up with a plan for the best use of what is a limited number of vaccine doses. 

Dr Taylor said Canada feels this experimental vaccine is a global resource, so in response they are sharing it with the international community. 

NEWS24/BBC